Chemotherapy-Induced Febrile Neutropenia
-
Subject Areas on Research
-
A comparison of international guidelines for the prevention of chemotherapy-induced neutropenia.
-
Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer.
-
Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review.
-
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer.
-
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
-
Management of chemotherapy-induced neutropenia: measuring quality, cost, and value.
-
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
-
Myeloid growth factors.
-
PAC1 Receptor Mediates Electroacupuncture-Induced Neuro and Immune Protection During Cisplatin Chemotherapy.
-
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.
-
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.
-
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
-
Treatment strategies for myeloid growth factors and intravenous iron: when, what, and how?
-
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.